|
DDX6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40607533896764E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.58170049175044E-10 |
| Normal-vs-Stage2 |
1.75811999999498E-05 |
| Normal-vs-Stage3 |
3.30959704086808E-11 |
| Normal-vs-Stage4 |
1.18810516980261E-11 |
| Stage1-vs-Stage2 |
8.945000E-01 |
| Stage1-vs-Stage3 |
7.982400E-02 |
| Stage1-vs-Stage4 |
1.622170E-03 |
| Stage2-vs-Stage3 |
1.902030E-01 |
| Stage2-vs-Stage4 |
2.389900E-02 |
| Stage3-vs-Stage4 |
1.769770E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.26294546937334E-13 |
| Normal-vs-AfricanAmerican |
2.023600E-02 |
| Normal-vs-Asian |
1.16280000073132E-08 |
| Caucasian-vs-AfricanAmerican |
3.638400E-02 |
| Caucasian-vs-Asian |
6.361200E-01 |
| AfricanAmerican-vs-Asian |
7.432000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.08080014224765E-10 |
| Normal-vs-Female |
7.000289237169E-12 |
| Male-vs-Female |
6.668600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.24870000187627E-09 |
| Normal-vs-Age(41-60Yrs) |
4.39015490627526E-12 |
| Normal-vs-Age(61-80Yrs) |
2.82750001190379E-09 |
| Normal-vs-Age(81-100Yrs) |
1.618800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.989800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.896800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.346200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.971200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.112800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.165200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.841400E-03 |
| Classical-VS-Follicular |
6.249500E-02 |
| Classical-VS-Other |
2.857200E-01 |
| Classical-VS-Normal |
5.96850013856454E-10 |
| Tall-VS-Follicular |
9.071800E-02 |
| Tall-VS-Other |
6.209800E-01 |
| Tall-VS-Normal |
3.86640053307019E-10 |
| Follicular-VS-Other |
7.065000E-01 |
| Follicular-VS-Normal |
7.4136999872465E-09 |
| Other-VS-Normal |
3.223400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.30290025832392E-10 |
| Normal-vs-N1 |
2.94899993313891E-10 |
| N0-vs-N1 |
1.112360E-01 |
|
|
